Shire plc Holding(s) In Company
December 04 2018 - 12:50PM
Dow Jones News
TIDMSHP
Holding(s) in Company
December 4, 2018 -- Shire plc (LSE: SHP, NASDAQ: SHPG)
1a. Identity of the issuer
or the underlying issuer of
existing shares to which voting Shire plc
rights are attached(ii) : (LEI: 54930005LQRLI2UXRQ59)
-------------------------------------------- -----------------------------------------------------
1b. Please indicate if the issuer is a non-UK issuer
(please mark with an "X" if appropriate)
---------------------------------------------------------------------------------------------------
Non-UK issuer
------------------------------------------------------------------------------------- ------------
2. Reason for the notification (please mark the appropriate
box or boxes with an "X")
---------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights X
------------------------------------------------------------------------------------- ------------
An acquisition or disposal of financial instruments
------------------------------------------------------------------------------------- ------------
An event changing the breakdown of voting rights
------------------------------------------------------------------------------------- ------------
Other (please specify)(iii) :
------------------------------------------------------------------------------------- ------------
3. Details of person subject to the notification obligation(iv)
Susan Kilsby (Chairman of
Name Shire plc and proxy holder)
City and country of registered
office (if applicable)
4. Full name of shareholder(s) (if different from 3.)(v)
---------------------------------------------------------------------------------------------------
Third parties holding ADRs
on behalf of the person identified
in box 3 and shareholders
appointing (i) the Chairman
of Shire plc as proxy and
(ii) a designate of Shire
Name plc as proxy.
-------------------------------------------- -----------------------------------------------------
City and country of registered
office (if applicable)
-------------------------------------------- -----------------------------------------------------
5. Date on which the threshold
was crossed or reached(vi)
: December 3, 2018
-------------------------------------------- -----------------------------------------------------
6. Date on which issuer notified
(DD/MM/YYYY): December 4, 2018
-------------------------------------------- -----------------------------------------------------
7. Total positions of person(s) subject to the notification
obligation
---------------------------------------------------------------------------------------------------
% of voting
rights attached % of voting rights Total number
to shares through financial Total of both of voting
(total of instruments (total of in % (8.A rights of
8. A) 8.B 1 + 8.B 2) + 8.B) issuer(vii)
------------------------ ------------------ ---------------------- --------------- ------------
Resulting
situation
on the date
on which threshold
was crossed
or reached 7.65% 7.65% 915,888,124
------------------------ ------- ---------------------- ----- ------------
Position of
previous notification
(if
applicable)
------------------------ ------------------ ---------------------- --------------- ------------
8. Notified details of the resulting situation on the
date on which the threshold was crossed or reached(viii)
--------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares
--------------------------------------------------------------------------------------------------------------
Number of voting rights(ix) % of voting rights
------------------
Class/type Direct Indirect Indirect
of (Art 9 of (Art 10 of Direct (Art 10 of
shares Directive Directive (Art 9 of Directive Directive
ISIN code (if 2004/109/EC) 2004/109/EC) 2004/109/EC) 2004/109/EC)
possible) (DTR5.1) (DTR5.2.1) (DTR5.1) (DTR5.2.1)
------------------- ------------- ---------------------- --------------------------------- ---------------
JE00B2QKY057
(Shire plc
Ordinary Shares
of 5 pence
each) 70,089,867 7.65%
------------------- ------------- ---------------------- --------------------------------- -----
SUBTOTAL 8.
A 70,089,867 7.65%
------------------- ------------------------------------- -----
B 1: Financial Instruments according to Art. 13(1)(a)
of Directive 2004/109/EC (DTR5.3.1.1 (a))
--------------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date(x) Conversion Period(xi) rights that rights
may be acquired
if the instrument
is
exercised/converted.
------------------- ------------- ---------------------- --------------------------------- ---------------
SUBTOTAL 8.
B 1
---------------------- --------------------------------- ---------------
B 2: Financial Instruments with similar economic effect
according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1
(b))
--------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Physical or cash Number % of voting
financial date(x) Conversion settlement(xii) of voting rights
instrument Period (xi) rights
------------------ -------------- ---------------------- ---------------- ---------------
SUBTOTAL
8.B.2
---------------- ---------------
9. Information in relation to the person subject to the
notification obligation (please mark the
applicable box with an "X")
Person subject to the notification obligation is
not controlled by any natural person or legal entity
and does not control any other undertaking(s) holding
directly or indirectly an interest in the (underlying)
issuer(xiii) X
Full chain of controlled undertakings through which
the voting rights and/or the
financial instruments are effectively held starting
with the ultimate controlling natural person or legal
entity(xiv) (please add additional rows as necessary)
------------------------------------------------------------- --------------------
% of voting rights
through financial
% of voting rights instruments if Total of both
if it equals it equals or if it equals
or is higher is higher than or is higher
than the notifiable the notifiable than the notifiable
Name(xv) threshold threshold threshold
------------ ------------------------- -------------------- --------------------
10. In case of proxy voting, please identify:
-----------------------------------------------------------------------------------
Susan Kilsby (Chairman of
Name of the proxy holder Shire plc)
--------------------------------------- ------------------------------------------
The number and % of voting
rights held 70,063,380 / 7.65%
--------------------------------------- ------------------------------------------
The date until which the voting The conclusion of Shire plc's
rights will be held General Meeting to be held
on December 5, 2018, or any
adjournment thereof.
--------------------------------------- ------------------------------------------
11. Additional information(xvi)
-----------------------------------------------------------------------------------
The number of indirect voting rights includes 70,063,380
voting rights, being the maximum number of discretionary
proxy votes held by the Chairman of Shire plc pursuant
to proxies received in respect of the resolution to be
considered by shareholders at the Shire plc General Meeting
to be held on December 5, 2018. These voting rights will
expire immediately upon the conclusion of the General
Meeting, or any adjournment thereof. The appointment
of a proxy shall not preclude a shareholder of Shire
plc from attending and voting in person at the General
Meeting.
-----------------------------------------------------------------------------------
Place of completion Dublin, Ireland
------------------- ----------------
Date of completion December 4, 2018
------------------- ----------------
For further information please contact:
Investor Relations
Christoph Brackmann christoph.brackmann@shire.com +41 41 288 41 29
Sun Kim sun.kim@shire.com +1 617 588 8175
Scott Burrows scott.burrows@shire.com +41 41 288 4195
Media
Katie Joyce kjoyce@shire.com +1 781 482 2779
NOTES TO EDITORS
About Shire
Shire is the global biotechnology leader serving patients with rare
diseases and specialized conditions. We seek to push boundaries through
discovering and delivering new possibilities for patient communities who
often have few or no other champions. Relentlessly on the edge of what's
next, we are serial innovators with a diverse pipeline offering fresh
thinking and new hope. Serving patients and partnering with healthcare
communities in over 100 countries, we strive to be part of the entire
patient journey to enable earlier diagnosis, raise standards of care,
accelerate access to treatment, and support patients. Our diverse
portfolio of therapeutic areas includes Immunology, Hematology, Genetic
Diseases, Neuroscience, Internal Medicine, and Ophthalmics.
Championing patients is our call to action - it brings the opportunity -
and responsibility - to change people's lives.
https://www.globenewswire.com/Tracker?data=Rg0dgSV9hJd_HNOJfV1nKNWLH4jTf9B2M_rGHpFmVlv2qYbOGvfYnLVxPyUC67RzjS5QUen1IQ4aM4rV5n6ibw==
www.shire.com
(END) Dow Jones Newswires
December 04, 2018 12:35 ET (17:35 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
Shire (NASDAQ:SHPGY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Shire (NASDAQ:SHPGY)
Historical Stock Chart
From Apr 2023 to Apr 2024
